期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Necessities and feasibilities of the establishment of traditional Chinese medicine clinical research protocol database
1
作者 Jin-Hua Si Nan Li +2 位作者 Liang Du Yao-Long Cheng Hong-Cai Shang 《TMR Integrative Medicine》 2018年第3期133-139,共7页
With the internationalization and modernization of traditional Chinese medicine (TCM), TCM clinical research has accumulated a lot of research information resources. However, these information resources are often sc... With the internationalization and modernization of traditional Chinese medicine (TCM), TCM clinical research has accumulated a lot of research information resources. However, these information resources are often scattered in various retrieval systems, which brings some difficulties to the reference and use of this information. Therefore, we collected TCM clinical research protocols which were published in international journals and established Traditional Chinese Medicine Clinical Research Protocol Database (TCMCRPD), in order to promote the localization of high-quality researches and improve the ability of TCM clinical research in China. After analyzing the major existing problems of TCM clinical research protocols, this essay describes the necessities and feasibilities of building Traditional Chinese Medicine Clinical Research Protocol Database (TCMCRPD) and puts forward some basic technological ideas, so as to provide a theoretical foundation for building the database. 展开更多
关键词 Traditional Chinese Medicine Clinical research Protocol database NECESSITY Feasibility
下载PDF
A Protocol for Developing a Clinical Practice Guideline for Therapeutic Drug Monitoring of Vancomycin 被引量:4
2
作者 叶志康 陈恳 +1 位作者 陈耀龙 翟所迪 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2016年第3期469-472,共4页
This study aimed to develop a guideline for therapeutic drug monitoring(TDM) of vancomycin. We adopted the new guideline definition from the Institute of Medicine(IOM), adhered closely to the six domains of the Ap... This study aimed to develop a guideline for therapeutic drug monitoring(TDM) of vancomycin. We adopted the new guideline definition from the Institute of Medicine(IOM), adhered closely to the six domains of the Appraisal of Guidelines for Research & Evaluation Ⅱ(AGREE Ⅱ), and made recommendations based on systematic reviews. We established a Guideline Steering Group and a Guideline Development Group, formulated 12 questions in the form of Population, Intervention, Comparison, Outcome(PICO) and completed a literature search. As far as we know, we will develop the first evidenced-based guideline for vancomycin TDM under the framework of the Grade of Recommendations Assessment, Development and Evaluation(GRADE). 展开更多
关键词 vancomycin therapeutic drug monitoring guideline Grade of Recommendations Assessment Development and Evaluation
下载PDF
Traditional Chinese Medicine guidelines for coronavirus disease 2019 被引量:8
3
作者 Liang Ning Ma Yanfang +29 位作者 Wang Jingya Li Huizhen Wang Xiaohui Jiao Liwen Liu Bin Ma Yan Zhao Chen Luo Xufei Zhao Siya Lu Meng Cao Jin Hu Wenpin Zhang Hairong Liu Guoxiu Lu Cheng Liu Mengyu Li Li Han Xuejie Liu Yuqi Wang Liying Zhao Xueyao Wei Dongfeng Bai Jing Sun Mingyu Yang Yong Wu Xiaodan Chen Yaolong Shi Nannan Wang Yanping Wang Yongyan 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2020年第6期891-896,共6页
OBJECTIVE:To summarize the evidence from Traditional Chinese Medicine(TCM)practice in the treatment of coronavirus disease 2019(COVID-19)and provide timely clinical practice guidance.METHODS:The guidelines were develo... OBJECTIVE:To summarize the evidence from Traditional Chinese Medicine(TCM)practice in the treatment of coronavirus disease 2019(COVID-19)and provide timely clinical practice guidance.METHODS:The guidelines were developed in accordance with the World Health Organization rapid guideline process.The evidence on TCM for COVID-19 from published guidelines,direct and indirect published clinical evidence,first hand clinical data,and expert experience and consensus were collected.The grading of recommendations assessment,development and evaluation(GRADE)method was used to grade the evidence and make the recommendations.RESULTS:Based on the available evidence,the guidelines recommended 17 Chinese medicines for COVID-19:2 Chinese herbal granules,7 Chinese patent medicines,and 8 Chinese herbal injections.CONCLUSION:As the literature search was conducted on March,any subsequent versions of these guidelines require an up-to-date literature review.We hope that the evidence summary in these guidelines will be helpful in global efforts to address COVID-19. 展开更多
关键词 COVID-19 MEDICINE Chinese traditional Practice guideline
原文传递
Toward Evidence-Based Chinese Medicine:Status Quo,Opportunities and Challenges 被引量:7
4
作者 CHEN Yao-long ZHAO Chen +11 位作者 ZHANG Li LI Bo WU Chuan-hong MU Wei WANG Jia-ying YANG Ke-hu LI You-ping CHEN Chiehfeng WANG Yong-yan WANG Chen BIAN Zhao-xiang SHANG Hong-cai 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第3期163-170,共8页
How to test the treatments of Chinese medicine(CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and research... How to test the treatments of Chinese medicine(CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM.For centuries,various approaches have been used to identify and measure the efficacy and safety of CM.However,the high-quality evidence related to CM that produced in China is still rare.Over the recent years,evidence-based medicine(EBM) has been increasingly applied to CM,strengthening its theoretical basis.This paper reviews the past and present state of CM,analyzes the status quo,challenges and opportunities of basic research,clinical trials,systematic reviews,clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China,pointing out how EBM can help to make CM more widely used and recognized worldwide. 展开更多
关键词 evidence-based medicine Chinese medicine randomized controlled trial systematic review clinical practice guidelines
原文传递
CSOG MFM Committee Guideline:Clinical Management Guidelines for Acute Fatty Liver of Pregnancy in China(2021) 被引量:1
5
作者 Maternal-Fetal Medicine Committee,Chinese Society of Obstetrics and Gynecology,Chinese Medical Ping Li +2 位作者 Yaolong Chen Weishe Zhang Huixia Yang 《Maternal-Fetal Medicine》 2021年第4期238-245,共8页
Acute fatty liver of pregnancy(AFLP)is a rare but critical obstetric-specific disease with a high fatality rate,posing a serious threat to the safety of mothers and infants.These guidelines were specially formulated t... Acute fatty liver of pregnancy(AFLP)is a rare but critical obstetric-specific disease with a high fatality rate,posing a serious threat to the safety of mothers and infants.These guidelines were specially formulated to standardize AFLP clinical pathways and to improve maternal and infant outcomes.Based on a two-round questionnaire survey,the guideline development team identified the following nine clinical issues that clinicians were most concerned about,and developed recommendations for each of them:prenatal outpatient screening for AFLP,diagnosis,preoperative risk assessment,delivery modes and timing,anesthesia methods,perinatal complications,selecting AFLP patients for artificial liver treatment,prognostic assessment,and monitoring during treatment.The guidelines cover the key issues related to AFLP diagnosis and treatment that concern clinicians. 展开更多
关键词 Fatty liver Acute fatty liver of pregnancy GUIDELINES Classification of evidence quality and strength of recommendation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部